{"name": "Cellerant Therapeutics",
 "permalink": "cellerant-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cellerant-therapeutics",
 "homepage_url": "http://www.cellerant.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cellerant.com",
 "phone_number": "650-232-2122",
 "description": "biotechnology company",
 "created_at": "Sat Sep 12 15:13:24 UTC 2009",
 "updated_at": "Mon Apr 22 21:57:46 UTC 2013",
 "overview": "\u003Cp\u003ECellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.\u003C/p\u003E\n\n\u003Cp\u003ECellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0005/9578/59578v1-max-150x150.jpg"],
     [[172,
       48],
      "assets/images/resized/0005/9578/59578v1-max-250x250.jpg"],
     [[172,
       48],
      "assets/images/resized/0005/9578/59578v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO Board of Director",
    "person":
     {"first_name": "Ram",
      "last_name": "Mandalam",
      "permalink": "ram-mandalam",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Government Operations and Controller",
    "person":
     {"first_name": "Sean",
      "last_name": "Givens",
      "permalink": "sean-givens",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/3894/253894v1-max-150x150.jpg"],
          [[189,
            189],
           "assets/images/resized/0025/3894/253894v1-max-250x250.jpg"],
          [[189,
            189],
           "assets/images/resized/0025/3894/253894v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President for Clinical Development",
    "person":
     {"first_name": "William",
      "last_name": "Reed",
      "permalink": "william-reed",
      "image": null}},
   {"is_past": false,
    "title": "Sr. Vice President, Regulatory, QA \u0026 Project Management",
    "person":
     {"first_name": "Margaret",
      "last_name": "Dillon",
      "permalink": "margaret-dillon",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/3864/253864v1-max-150x150.jpg"],
          [[170,
            170],
           "assets/images/resized/0025/3864/253864v1-max-250x250.jpg"],
          [[170,
            170],
           "assets/images/resized/0025/3864/253864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chairman, Board of Directors",
    "person":
     {"first_name": "Lowell",
      "last_name": "Sears",
      "permalink": "lowell-sears",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Corporate Development",
    "person":
     {"first_name": "Jun",
      "last_name": "S.Yoon",
      "permalink": "jun-s-yoon",
      "image": null}},
   {"is_past": false,
    "title": "Board Of Directors",
    "person":
     {"first_name": "Richard",
      "last_name": "Chyette",
      "permalink": "richard-chyette",
      "image": null}},
   {"is_past": false,
    "title": "Board Of Directors",
    "person":
     {"first_name": "Richard",
      "last_name": "G.Rathmann",
      "permalink": "richard-g-rathmann",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Research \u0026 Development ",
    "person":
     {"first_name": "Rob",
      "last_name": "Tessler",
      "permalink": "rob-tessler",
      "image": null}},
   {"is_past": false,
    "title": "Executive Director of Manufacturing and Process Sciences",
    "person":
     {"first_name": "Gautam",
      "last_name": "Banik",
      "permalink": "gautam-banik",
      "image": null}},
   {"is_past": false,
    "title": "Board Of Directors",
    "person":
     {"first_name": "Steve",
      "last_name": "Greenberg",
      "permalink": "steve-greenberg",
      "image": null}},
   {"is_past": false,
    "title": "Board Of Directors",
    "person":
     {"first_name": "Gisela",
      "last_name": "S. Schwab",
      "permalink": "gisela-s-schwab",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$37.1M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://deals.venturebeat.com/2007/04/26/cellerant-therapeutics-raises-44m-for-stem-cell-therapeutics/",
    "source_description": "Cellerant Therapeutics raises $4.4M for stem-cell therapeutics",
    "raised_amount": 4400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://cellerant.com/pdf/press_050511.pdf",
    "source_description": "CELLERANT THERAPEUTICS RAISES $16 MILLION TO ADVANCE STEM CELL-BASED THERAPIES FOR LIFE-THREATENING DISEASES",
    "raised_amount": 16000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 5,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novel Bioventures",
         "permalink": "novel-bioventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "CX Venture Group",
         "permalink": "cx-venture-group",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0010/1197/101197v2-max-150x150.png"],
             [[207,
               60],
              "assets/images/resized/0010/1197/101197v2-max-250x250.png"],
             [[207,
               60],
              "assets/images/resized/0010/1197/101197v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Allen \u0026 Company",
         "permalink": "allen-and-company",
         "image":
          {"available_sizes":
            [[[150,
               61],
              "assets/images/resized/0016/9557/169557v4-max-150x150.png"],
             [[208,
               85],
              "assets/images/resized/0016/9557/169557v4-max-250x250.png"],
             [[208,
               85],
              "assets/images/resized/0016/9557/169557v4-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110916e79g00001\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Cellerant Thera Awarded Additional $16.7M For Radiation Treatment ",
    "raised_amount": 16700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BARDA",
         "permalink": "barda",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "1561 Industrial Road",
    "address2": "",
    "zip_code": "94070",
    "city": "San Carlos",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.4993106,
    "longitude": -122.2427204}],
 "milestones":
  [{"description": "Cellerant lands $153M BARDA contract for ARS program",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 1,
    "source_url": "http://www.fiercebiotech.com/story/cellerant-nails-153m-barda-contract-ars-program/2010-09-01?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Cellerant lands $153M BARDA contract for ARS program",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cellerant Therapeutics",
      "permalink": "cellerant-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}